Indication

Treatment of severe osteoporosis in postmenopausal women at high risk of fracture.

Medicine details

Medicine name:
romosozumab (Evenity)
SMC ID:
SMC2280
Pharmaceutical company
UCB Pharma Ltd
BNF chapter
Musculoskeletal and joint diseases
Submission type
Full
Publication due date:
TBC
SMC meeting date:
TBC
Patient group submission deadline:
TBC